AdvancingCell Stabilization Technology

Cellphire, Inc. is a biotechnology company focusing on cell stabilization technology with a current emphasis on blood platelets.

Cellphire has developed a proprietary method for the long-term stabilization of platelets in the dry state.
Thrombosomes® are currently in a Phase 1 clinical trial. Learn more.
For more Cellphire product development efforts, visit the Our Technology page.

News Releases

ROCKVILLE, MD, January 15, 2019 -- Cellphire, Inc., the global leader in long-term stabilization and...Read More »

ROCKVILLE, MD, May 1, 2018 -- Cellphire, Inc., the global leader in long-term stabilization and stor...Read More »

ROCKVILLE, MD, MARCH 1, 2018 -- Cellphire, Inc., the global leader in long-term stabilization and st...Read More »

More Articles »

Have Questions?Reach us here

Please enter your information below

Cellphire Veterinary Subsidiary BODEVET, INC. Launches First Commercial Product 

Copyright © 2019 // Website Developed by VisionFriendly.com